1-203683316-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001684.5(ATP2B4):​c.111A>G​(p.Ser37Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.886 in 1,614,012 control chromosomes in the GnomAD database, including 635,665 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 53556 hom., cov: 32)
Exomes 𝑓: 0.89 ( 582109 hom. )

Consequence

ATP2B4
NM_001684.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.54
Variant links:
Genes affected
ATP2B4 (HGNC:817): (ATPase plasma membrane Ca2+ transporting 4) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-203683316-A-G is Benign according to our data. Variant chr1-203683316-A-G is described in ClinVar as [Benign]. Clinvar id is 1598820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.54 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B4NM_001684.5 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 21 ENST00000357681.10 NP_001675.3 P23634-6A0A024R968
ATP2B4NM_001001396.3 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 22 NP_001001396.1 P23634-2
ATP2B4NM_001365783.2 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 21 NP_001352712.1
ATP2B4NM_001365784.2 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 21 NP_001352713.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B4ENST00000357681.10 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 21 1 NM_001684.5 ENSP00000350310.5 P23634-6
ATP2B4ENST00000341360.7 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 22 1 ENSP00000340930.2 P23634-2
ATP2B4ENST00000705901.1 linkc.111A>G p.Ser37Ser synonymous_variant Exon 2 of 21 ENSP00000516177.1 P23634-3

Frequencies

GnomAD3 genomes
AF:
0.833
AC:
126625
AN:
152042
Hom.:
53548
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.682
Gnomad AMI
AF:
0.939
Gnomad AMR
AF:
0.902
Gnomad ASJ
AF:
0.908
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.855
Gnomad FIN
AF:
0.822
Gnomad MID
AF:
0.918
Gnomad NFE
AF:
0.890
Gnomad OTH
AF:
0.859
GnomAD2 exomes
AF:
0.883
AC:
221989
AN:
251452
AF XY:
0.883
show subpopulations
Gnomad AFR exome
AF:
0.674
Gnomad AMR exome
AF:
0.944
Gnomad ASJ exome
AF:
0.900
Gnomad EAS exome
AF:
0.999
Gnomad FIN exome
AF:
0.829
Gnomad NFE exome
AF:
0.889
Gnomad OTH exome
AF:
0.891
GnomAD4 exome
AF:
0.891
AC:
1302603
AN:
1461852
Hom.:
582109
Cov.:
61
AF XY:
0.890
AC XY:
647305
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.665
AC:
22263
AN:
33478
American (AMR)
AF:
0.940
AC:
42054
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.900
AC:
23519
AN:
26134
East Asian (EAS)
AF:
1.00
AC:
39690
AN:
39700
South Asian (SAS)
AF:
0.858
AC:
74038
AN:
86252
European-Finnish (FIN)
AF:
0.830
AC:
44318
AN:
53418
Middle Eastern (MID)
AF:
0.891
AC:
5137
AN:
5768
European-Non Finnish (NFE)
AF:
0.897
AC:
997832
AN:
1111984
Other (OTH)
AF:
0.890
AC:
53752
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
8149
16298
24448
32597
40746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21432
42864
64296
85728
107160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.832
AC:
126668
AN:
152160
Hom.:
53556
Cov.:
32
AF XY:
0.831
AC XY:
61846
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.681
AC:
28231
AN:
41470
American (AMR)
AF:
0.902
AC:
13795
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.908
AC:
3150
AN:
3470
East Asian (EAS)
AF:
0.999
AC:
5172
AN:
5176
South Asian (SAS)
AF:
0.854
AC:
4123
AN:
4826
European-Finnish (FIN)
AF:
0.822
AC:
8711
AN:
10598
Middle Eastern (MID)
AF:
0.915
AC:
269
AN:
294
European-Non Finnish (NFE)
AF:
0.890
AC:
60542
AN:
68014
Other (OTH)
AF:
0.860
AC:
1819
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1027
2054
3082
4109
5136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.878
Hom.:
128617
Bravo
AF:
0.835
Asia WGS
AF:
0.926
AC:
3221
AN:
3478
EpiCase
AF:
0.894
EpiControl
AF:
0.889

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.054
DANN
Benign
0.34
PhyloP100
-3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1419114; hg19: chr1-203652444; COSMIC: COSV108174121; API